Merge Talks Between The EVERY Co and Onego Bio
The EVERY Co and Onego Bio were discussing a $400m merger before talks broke down, according to court documents.
Alt-egg startups The EVERY Company and Onego Bio had planned to create a new company, but Onego Bio later sued its rival.
Patent Dispute
The lawsuit, filed in a Wisconsin court, seeks to invalidate one of The EVERY Co's patents covering the production of ovalbumin via precision fermentation.
- The EVERY Co uses yeast (Komagataella phaffii) as its host microorganism.
- Onego Bio uses fungus (Trichoderma reesei).
The dispute centers on whether Onego is infringing a “foundational” patent from The EVERY Co covering ovalbumin expression in a range of hosts.
The EVERY Co has urged the court to dismiss the lawsuit.
Author's summary: Merger talks failed between The EVERY Co and Onego Bio.
More News
- Queer Jams of the Week: New Music From Tyler, the Creator, Reneé Rapp, Orville Peck & More
- Friday Dance Music Guide: The Week’s Best New Tracks From Sub Focus & Grimes, Eli Brown & More
- Hannah's future stolen by jealous, angry act of horror
- Material Memory: What We Lose When We Demolish Buildings
- The unexpected reaction of Tyreek Hill after the firing of Dolphins general manager Chris Grier
- Sinners: blood, blues and vampires - The Stute
- Amazon’s newest streaming stick is missing a Spotify app.